Project

Sanofi GCA EFC15068

Aborted ยท 2019 until 2020

Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2019
End Date
2020
Financing
Industry
Brief description/objective

A randomized, double-blind, placebo-controlled study to evaluate the efficacy and
safety of sarilumab in patients with giant cell arteritis